Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5079262 | DUSA | Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid |
Sep, 2013
(10 years ago) | |
US5954703 | DUSA | Method and apparatus for applying 5-aminolevulinic acid |
Oct, 2017
(6 years ago) | |
US8758418 | DUSA | Illuminator for photodynamic therapy |
May, 2018
(6 years ago) | |
US8216289 | DUSA | Illuminator for photodynamic therapy |
May, 2018
(6 years ago) | |
US6709446 | DUSA | Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light |
May, 2018
(6 years ago) | |
US7723910 | DUSA | Method of photodynamically diagnosing or treating a contoured surface |
Jun, 2019
(4 years ago) | |
US11077192 | DUSA | Methods for photodynamic therapy |
Jan, 2038
(13 years from now) | |
US11690914 | DUSA | Methods for photodynamic therapy |
Jan, 2038
(13 years from now) | |
US10357567 | DUSA | Methods for photodynamic therapy |
Jan, 2038
(13 years from now) | |
US11135293 | DUSA | Methods for photodynamic therapy |
Jan, 2038
(13 years from now) | |
US11571478 | DUSA | Methods for photodynamic therapy |
Jan, 2038
(13 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Indication(I-766) | Mar 09, 2021 |
M(M-82) | Mar 12, 2013 |
Drugs and Companies using AMINOLEVULINIC ACID HYDROCHLORIDE ingredient
Market Authorisation Date: 03 December, 1999
Treatment: Treatment of non-hyperkeratotic actinic keratoses of face and scalp; Treatment of actinic keratoses of upper extremities by photodynamic therapy
Dosage: SOLUTION;TOPICAL